All lobbying filings

WILLIAMS AND JENSEN, PLLC

Lobbying for AMGEN, INC. · An American multinational biopharmaceutical company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $60,000.00 income · posted Jul 18, 2025

Official filing document

Bills named in this filing 1

HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

Lobbying activity 6

Issues related to patent protections.

Health Issues

General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Policies impacting public health preparedness and prevention. Policies impacting Cardiovascular health. Pharmacy benefit manager reform proposals.

Medicare/Medicaid

General education about policies impacting pharmaceutical development, approval, reimbursement, Medicare Part D and Medicare Part B, and 340B policies. Pharmacy benefit manager reform proposals. H.R. 1, "One Big Beautiful Bill Act".

Taxation/Internal Revenue Code

Tax issues related to the pharmaceutical industry. H.R. 1, "One Big Beautiful Bill Act".

Budget/Appropriations

Policies impacting disease prevention.

Labor Issues/Antitrust/Workplace

Issues related to antitrust legislation.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.